世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

生体電気医療市場の市場規模、シェア、動向分析レポート:タイプ別(埋め込み型電気医療機器、非侵襲型電気医療機器)、製品別、用途別、最終用途別、地域別、セグメント別予測、2023年~2030年


Bioelectric Medicine Market Size, Share & Trends Analysis Report By Type (Implantable Electroceutical Devices, Non-invasive Electroceutical Devices), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

生体電気医療市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の生体電気医薬市場規模は、2023年から2030年にかけて年平均成長率6.1%を記録し、2030年までに354億2000万米ドルに達す... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年12月4日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
96 英語

1~3営業日


 

サマリー

生体電気医療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の生体電気医薬市場規模は、2023年から2030年にかけて年平均成長率6.1%を記録し、2030年までに354億2000万米ドルに達すると予測されています。市場を牽引する主な要因としては、老人人口の増加、主要企業による戦略的イニシアティブ、先端電気医療/生体電気医薬品の研究開発投資の増加などが挙げられる。2022年4月、コクレアはデマントの聴覚インプラント事業であるオーティコン・メディカルの買収に合意した。これにより、同社は研究開発投資と市場成長活動を拡大し、より大きな規模を手に入れることができる。

ユーロスタットによると、2021年にはEUの人口の約20.8%、5分の1以上が65歳以上となる。高齢化社会は、アルツハイマー病、てんかん、不整脈、パーキンソン病、うつ病などの医療障害を引き起こしやすい。したがって、これが市場成長の主な要因となっている。これらの疾患の治療には、人工内耳、植え込み型除細動器、心臓ペースメーカー、脊髄刺激装置などの先進バイオエレクトロニクスデバイスが使用されている。

先進的な電気製剤の研究開発への投資が増加していることも、市場の成長を支える主な要因である。例えば、2021年にMedtronicは先端製品開発のための研究開発に約25億米ドルを投資した。ElectroCore社によると、米国では毎年32万5,000人近くが群発頭痛を経験している。同社は、2018年にFDAの認可を受けたgammaCoreと呼ばれる製品を開発することで、この機会を利用した。この製品は、成人の痛みを伴う頭痛の管理に有用な非侵襲的VNS療法に適応される。

生体電気医療市場レポートハイライト

- 製品別では、植え込み型除細動器分野が、不整脈とCHFの治療におけるこれらの製品の広範な応用により、2022年に最大の収益を生み出す分野となった。

- 植え込み型電気治療器タイプは、技術の進歩により2022年に最大の収益シェアを占める

- 応用分野では、不整脈分野が2022年に最大のシェアを占め、予測期間中も支配的な地位を維持すると予想される。

- 2022年には、病院における電気治療器移植手術の増加により、病院エンドユーザー分野が市場を支配した。

- 北米市場は2022年に最大の収益シェアを占めたが、これは同地域に医療機器企業が多いことが主因である。

- アジア太平洋地域は、予測期間中に最も速い成長率を記録すると予想される。中国やインドなどのアジア諸国における医療インフラの発展や医療意識の高まりが、この地域市場の成長に寄与する主な要因である。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Bioelectric Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Bioelectric Medicine Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technological landscape
3.4.2.5. Environment landscape
3.4.2.6. Legal Landscape
Chapter 4. Bioelectric Medicine Market: Product Estimates & Trend Analysis
4.1. Bioelectric Medicine Market: Key Takeaways
4.2. Bioelectric Medicine Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Implantable Cardioverter Defibrillators
4.3.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Cardiac Pacemakers
4.4.1. Cardiac pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cochlear Implants
4.5.1. Cochlear implants market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Spinal Cord Stimulators
4.6.1. Spinal cord stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Deep Brain Stimulators
4.7.1. Deep brain stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Transcutaneous Electrical Nerve Stimulators
4.8.1. Transcutaneous electrical nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Sacral Nerve Stimulators
4.9.1. Sacral nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Vagus Nerve Stimulators
4.10.1. Vagus nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Others
4.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Bioelectric Medicine Market: Type Estimates & Trend Analysis
5.1. Bioelectric Medicine Market: Key Takeaways
5.2. Bioelectric Medicine Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Implantable Electroceutical Devices
5.3.1. Implantable electroceutical devices market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Non-Invasive Electroceutical Devices
5.4.1. Non-invasive electroceutical devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Bioelectric Medicine Market: Application Estimates & Trend Analysis
6.1. Bioelectric Medicine Market: Key Takeaways
6.2. Bioelectric Medicine Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Arrhythmia
6.3.1. Arrhythmia market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Pain Management
6.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Sensorineural Hearing Loss
6.5.1. Sensorineural hearing loss market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Parkinson’s Disease
6.6.1. Parkinson’s disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Tremor
6.7.1. Tremor market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Depression
6.8.1. Depression market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Treatment-resistant Depression
6.9.1. Treatment-resistant depression market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Epilepsy
6.10.1. Epilepsy market estimates and forecasts, 2018 to 2030 (USD Million)
6.11. Urinary and Fecal Incontinence
6.11.1. Urinary and fecal incontinence market estimates and forecasts, 2018 to 2030 (USD Million)
6.12. Others
6.12.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Bioelectric Medicine Market: End-use Estimates & Trend Analysis
7.1. Bioelectric Medicine Market: Key Takeaways
7.2. Bioelectric Medicine Market: End-use Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Others
7.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Bioelectric Medicine Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Bioelectric Medicine Market by Region: Key Marketplace Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.5. South Korea
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Medtronic
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Boston Scientific Corporation
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Cochlear Ltd.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. LivaNova PLC
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Biotronik SE & Co. KG
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. electroCore, Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Sonova
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Nevro Corp.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Stimwave LLC
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Bioelectric Medicine Market Growth & Trends

The global bioelectric medicine market size is expected to reach USD 35.42 billion by 2030, registering a CAGR of 6.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market include the rising geriatric population, strategic initiatives by key companies, and increasing investment in R&D for advanced electroceuticals/ bioelectric medicines. In April 2022, Cochlear agreed to acquire Demant's hearing implants business - Oticon Medical. This would enable the company to increase its R&D investments and market growth activities and provide it with greater scale.

In 2021, around 20.8% or more than one-fifth of the population in the EU was aged 65 and over, according to Eurostat. The aging population is prone to medical disorders such as Alzheimer's disease, epilepsy, cardiac arrhythmias, Parkinson's disease, and depression. Hence, this is a key factor contributing to the market growth. Advanced bioelectronic devices including cochlear implants, implantable cardioverter defibrillators, cardiac pacemakers, and spinal cord stimulators are used for the treatment of these conditions.

Growing investments in the R&D of advanced electroceuticals is another major factor supporting the growth of the market. For example, in 2021, Medtronic invested around USD 2.5 billion in R&D for the development of advanced products. According to ElectroCore, almost 325,000 people in the U.S. experience cluster headaches every year. The company capitalized on the opportunity by developing a product called gammaCore, which received FDA clearance in 2018. The product is indicated for non-invasive VNS therapy helpful in managing painful headaches in adults.

Bioelectric Medicine Market Report Highlights

• By product, the implantable cardioverter defibrillators segment was the largest revenue-generating segment in 2022 owing to the wider application of these products in the treatment of arrhythmia and CHF

• The implantable electroceutical devices type segment accounted for the largest revenue share in 2022 owing to technological advancements

• In the application segment, the arrhythmia segment accounted for the largest share in 2022 and is expected to remain dominant throughout the forecast period

• The hospital end-user segment dominated the market in 2022 due to the escalating number of electroceutical device implant procedures in hospitals

• The North American market accounted for the largest revenue share in 2022 mainly due to a large number of medical devices companies in this region

• The Asia Pacific region is expected to register the fastest growth rate over the forecast period. The developing healthcare infrastructure and rising healthcare awareness in Asian countries such as China and India are major factors contributing to the growth of this regional market



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Bioelectric Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Bioelectric Medicine Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technological landscape
3.4.2.5. Environment landscape
3.4.2.6. Legal Landscape
Chapter 4. Bioelectric Medicine Market: Product Estimates & Trend Analysis
4.1. Bioelectric Medicine Market: Key Takeaways
4.2. Bioelectric Medicine Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Implantable Cardioverter Defibrillators
4.3.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Cardiac Pacemakers
4.4.1. Cardiac pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cochlear Implants
4.5.1. Cochlear implants market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Spinal Cord Stimulators
4.6.1. Spinal cord stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Deep Brain Stimulators
4.7.1. Deep brain stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Transcutaneous Electrical Nerve Stimulators
4.8.1. Transcutaneous electrical nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Sacral Nerve Stimulators
4.9.1. Sacral nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Vagus Nerve Stimulators
4.10.1. Vagus nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Others
4.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Bioelectric Medicine Market: Type Estimates & Trend Analysis
5.1. Bioelectric Medicine Market: Key Takeaways
5.2. Bioelectric Medicine Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Implantable Electroceutical Devices
5.3.1. Implantable electroceutical devices market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Non-Invasive Electroceutical Devices
5.4.1. Non-invasive electroceutical devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Bioelectric Medicine Market: Application Estimates & Trend Analysis
6.1. Bioelectric Medicine Market: Key Takeaways
6.2. Bioelectric Medicine Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Arrhythmia
6.3.1. Arrhythmia market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Pain Management
6.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Sensorineural Hearing Loss
6.5.1. Sensorineural hearing loss market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Parkinson’s Disease
6.6.1. Parkinson’s disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Tremor
6.7.1. Tremor market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Depression
6.8.1. Depression market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Treatment-resistant Depression
6.9.1. Treatment-resistant depression market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Epilepsy
6.10.1. Epilepsy market estimates and forecasts, 2018 to 2030 (USD Million)
6.11. Urinary and Fecal Incontinence
6.11.1. Urinary and fecal incontinence market estimates and forecasts, 2018 to 2030 (USD Million)
6.12. Others
6.12.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Bioelectric Medicine Market: End-use Estimates & Trend Analysis
7.1. Bioelectric Medicine Market: Key Takeaways
7.2. Bioelectric Medicine Market: End-use Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Others
7.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Bioelectric Medicine Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Bioelectric Medicine Market by Region: Key Marketplace Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5.5. South Korea
8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Medtronic
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Boston Scientific Corporation
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Cochlear Ltd.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. LivaNova PLC
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Biotronik SE & Co. KG
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. electroCore, Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Sonova
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Nevro Corp.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Stimwave LLC
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(medicine)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18 10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る